LDN Radio Show

LDN should be considered a first-line therapy for CFS/FM (2019 Conference) (LDN, low dose naltrexone)

Kent Holtorf, MD discusses the multisystem nature and cycle of chronic disorders such as Lyme disease, CFS, fibromyalgia, and ME, and the role that immune dysfunction, inflammation, and TH1-TH2 shift have in such disorders. He presents immune modulating therapies that address multisystem diseases, including LDN and others.

A Medication to Gain Self-Awareness: Treatment of Dissociative Symptoms in Trauma-Related Disorder I (2017 Conference) (LDN, low dose naltrexone)

Dr Wiebke Pape shares her presentation on Self-Awareness at The LDN 2017 Conference.

Dr Wiebke Pape introduces her presentation by discussing the treatment of dissociative symptoms in trauma-related disorders. The dissociative symptoms of traumatic stress include dissociative amnesia (alterations in memory), derealisation (external world seems unreal) and depersonalisation (altered self-awareness).

Traumatic Brain Injury: Low Dose Naltrexone and Microglial Modification (2019 Conference) (LDN, low dose naltrexone)

Sarah Zielsdorf is a very experienced doctor who has extensive knowledge about Low Dose Naltrexone (LDN). In this presentation on Traumatic Brain Injury, she describes in great detail how our systems function and respond to various brain injuries. She describes treatments including LDN. The content is very technical and likely most understood by professionals, but very interesting. She discusses levels of brain injury, concussion effects on the brain and gut permeability, therapeutic foods, and treatment approaches.

Jill Brook MA – Fasting and Autoimmunity: New Promising Findings

It has long been known that fasting can reduce inflammation and autoimmunity, and may extend life, however this strategy isn’t considered widely practical and has safety concerns. This presentation will describe several methods of intermittent fasting, with an emphasis on the fast-mimicking diet.  It will explain the protocol, share a typical menu, and explain how it causes the body to destroy autoantibodies and then trigger stem cell regeneration to promote new healthy tissue growth.  Finally, Jill will share some practical tips from her experience helping her clients with the diet.

LDN Use in Cognitive Decline, Lyme Disease, and Hashimoto’s Thyroiditis (2019 Conference)

Pamela Smith, MD discusses memory and memory impairment types, eg age-related and mild cognitive; and dementias, such as Alzheimer’s Disease and diabetes. Some foods can contribute to causing declines, while some foods can help. The importance of good sleep hygiene and exercise are stressed, as well as removing toxins. Hormonal imbalance and some infections may cause cognitive decline. The benefits of melatonin, DHEA, and various brain nutrients are discussed.

Treating Depression in Patients with Autoimmune Conditions (2019 Conference) 

In this presentation Dr Livengood discusses how to treat depression in patients with autoimmune diseases.  Dr Livengood shares case studies of patients who suffer from depression and autoimmune disease, treating the patient holistically helped so much more than treating the individual illness. Recognising that there is much more going on with a patient than just the main symptom described.